Skip to main content

Mr Samuel Ford

Consultant Upper GI Surgeon

PhD, FRCS

Practises at: The Droitwich Spa Hospital, The Priory Hospital

Mr-Samuel-Ford-General-Surgery

Personal Profile

Mr Samuel Ford is a full time Consultant surgeon at the Queen Elizabeth Hospital, Birmingham with a specialist interest in general, upper gastrointestinal and sarcoma surgery.

He trained in general and upper GI surgery in the South West and after completion of training in 2014 undertook further specialist fellowships in sarcoma surgery in Birmingham and Milan.

Mr Ford was awarded a PhD in cancer biology from the University of Birmingham following a three year period as the Cancer Research UK Clinical Research Fellow. His research portfolio is centred on optimising outcomes for patients with soft tissue sarcoma and he has contributed to international consensus statements and published papers on the management of sarcoma and gastrointestinal stromal tumours.

Mr Ford is an honorary senior lecturer at the University of Birmingham. As well as soft tissue sarcoma, he has a keen interest in neuroendocrine tumours and gastro-intestinal stromal tumours. Mr Ford is also a specialist in the management of benign disease, especially hiatal hernias, acid reflux, gallstones, abdominal wall hernias and lipomas.

Clinical Interests

I have a specialist interest in upper GI surgery including laparoscopic cholecystectomy, anti-reflux surgery and repair of hiatal hernias.

I offer a full range of operative techniques for repair of abdominal wall hernias including laparoscopic inguinal hernia repair (TEP).

I am a specialist in the surgical management of soft tissue sarcomas, neuroendocrine tumours (NETs) and gastrointestinal tumours (GIST).

As part of my work as a sarcoma surgeon I see a lot of patients with lumps and bumps including lipomas.

Professional Memberships

  • General Medical Council
  • British Medical Association
  • Association of Upper GI Surgeons
  • British Sarcoma Group
  • Connective Tissue Oncology Society
  • European Organisation for Research and Treatment of Cancer
i